TRIB3 overexpression predicts malignant progression and poor prognosis in human solid tumors: bioinformatics validation and clinical significance
TRIB3 overexpression is significantly linked to malignant progression and unfavorable prognosis in diverse solid tumors. These results suggest that TRIB3 holds promise as a biomarker and therapeutic target in human cancers.
Authors
- Kexin Ren
- Chen Shen (ORCID: https://orcid.org/0000-0002-4325-5957)
- Kangping Yang (ORCID: https://orcid.org/0000-0003-1298-0846)
- Xiangfei Liu
- Xuan Xu (ORCID: https://orcid.org/0000-0001-5402-8410)
- Huizi Li (ORCID: https://orcid.org/0000-0003-2920-7665)
- X Q Lyu
- Zilu Yu
- Benjie Li
Institutions
- Nanchang University (CN)
- Ludong University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- Beijing Hospital (CN)
Publication Details
- Journal
- Expert Review of Molecular Diagnostics
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1080/14737159.2024.2436391
- Citations
- 3
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 0.72